Atlas Trials

An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users

Clinical trial NCT06097676 · COMPLETED

Trial details

NCT number
NCT06097676
Sponsor
Arbor Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Abuse Potential
Start date
2021-09-28
Primary completion
2022-06-30
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.